FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1756388641> ?p ?o ?g. }

• W1756388641 endingPage "3139" @default.
• W1756388641 startingPage "3131" @default.
• W1756388641 abstract "Abstract The TLR9 agonist CpG-oligodeoxynucleotide (CpG-ODN) with a phosphorothioate backbone (PTO-CpG-ODN) is evaluated in clinical trials as a vaccine adjuvant or as treatment of cancers. Bone morphogenetic proteins (BMPs) regulate growth and differentiation of several cell types, and also induce apoptosis of cancer cells. Cross-talk between BMP- and TLR-signaling has been reported, and we aimed to investigate whether CpG-ODN influenced BMP-induced osteoblast differentiation or BMP-induced apoptosis of malignant plasma cells. We found that PTO-CpG-ODN inhibited BMP-2–induced osteoblast differentiation from human mesenchymal stem cells. Further, PTO-CpG-ODN counteracted BMP-2– and BMP-6–induced apoptosis of the human myeloma cell lines IH-1 and INA-6, respectively. In contrast, PTO-CpG-ODN did not antagonize the antiproliferative effect of BMP-2 on hMSCs or IH-1 cells. Inhibition of Smad-signaling and p38 MAPK-signaling indicated that apoptosis of IH-1 cells is dependent on Smad-signaling downstream of BMP, whereas the antiproliferative effect of BMP-2 on IH-1 cells also involves p38 MAPK-signaling. Together, the data suggested a specific inhibition by PTO-CpG-ODN on BMP–Smad-signaling. Supporting this we found that PTO-CpG-ODN inhibited BMP-induced phosphorylation of receptor-Smads in human mesenchymal stem cells and myeloma cell lines. This effect appeared to be independent of TLR9 because GpC-ODN and other ODNs with the ability to form multimeric structures inhibited Smad-signaling as efficiently as PTO-CpG-ODNs, and because knockdown of TLR9 by small interfering RNA in INA-6 cells did not blunt the effect of PTO-CpG-ODN. In conclusion, our results demonstrate that PTO-CpG-ODN inhibits BMP-signaling, and thus might provoke unwanted TLR9-independent side effects in patients." @default.
• W1756388641 created "2016-06-24" @default.
• W1756388641 creator A5025598471 @default.
• W1756388641 creator A5026161908 @default.
• W1756388641 creator A5031006818 @default.
• W1756388641 creator A5042045753 @default.
• W1756388641 creator A5049608650 @default.
• W1756388641 creator A5056712587 @default.
• W1756388641 creator A5073991373 @default.
• W1756388641 date "2010-09-15" @default.
• W1756388641 modified "2023-10-15" @default.
• W1756388641 title "CpG-Oligodeoxynucleotide Inhibits Smad-Dependent Bone Morphogenetic Protein Signaling: Effects on Myeloma Cell Apoptosis and In Vitro Osteoblastogenesis" @default.
• W1756388641 cites W1480584300 @default.
• W1756388641 cites W1510227107 @default.
• W1756388641 cites W1514540900 @default.
• W1756388641 cites W1602603948 @default.
• W1756388641 cites W1819432277 @default.
• W1756388641 cites W1877684281 @default.
• W1756388641 cites W1917892434 @default.
• W1756388641 cites W1972124518 @default.
• W1756388641 cites W1972800847 @default.
• W1756388641 cites W1976808787 @default.
• W1756388641 cites W1977379434 @default.
• W1756388641 cites W1980179678 @default.
• W1756388641 cites W1980213997 @default.
• W1756388641 cites W1983672040 @default.
• W1756388641 cites W1984618863 @default.
• W1756388641 cites W1987207704 @default.
• W1756388641 cites W1988897265 @default.
• W1756388641 cites W1989451500 @default.
• W1756388641 cites W1991753648 @default.
• W1756388641 cites W2000959419 @default.
• W1756388641 cites W2002084575 @default.
• W1756388641 cites W2004726009 @default.
• W1756388641 cites W2007331685 @default.
• W1756388641 cites W2011401809 @default.
• W1756388641 cites W2019376007 @default.
• W1756388641 cites W2024168530 @default.
• W1756388641 cites W2025412364 @default.
• W1756388641 cites W2035653659 @default.
• W1756388641 cites W2037325698 @default.
• W1756388641 cites W2039461003 @default.
• W1756388641 cites W2042939195 @default.
• W1756388641 cites W2044115042 @default.
• W1756388641 cites W2047642636 @default.
• W1756388641 cites W2057980850 @default.
• W1756388641 cites W2058308851 @default.
• W1756388641 cites W2059147394 @default.
• W1756388641 cites W2072200539 @default.
• W1756388641 cites W2072239295 @default.
• W1756388641 cites W2076220903 @default.
• W1756388641 cites W2080838269 @default.
• W1756388641 cites W2082013812 @default.
• W1756388641 cites W2083974181 @default.
• W1756388641 cites W2090826831 @default.
• W1756388641 cites W2093271566 @default.
• W1756388641 cites W2094855916 @default.
• W1756388641 cites W2101760818 @default.
• W1756388641 cites W2108663319 @default.
• W1756388641 cites W2121086400 @default.
• W1756388641 cites W2124571983 @default.
• W1756388641 cites W2130775443 @default.
• W1756388641 cites W2145303019 @default.
• W1756388641 cites W2149817160 @default.
• W1756388641 cites W2152521795 @default.
• W1756388641 cites W2159590253 @default.
• W1756388641 doi "https://doi.org/10.4049/jimmunol.0903605" @default.
• W1756388641 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20702733" @default.
• W1756388641 hasPublicationYear "2010" @default.
• W1756388641 type Work @default.
• W1756388641 sameAs 1756388641 @default.
• W1756388641 citedByCount "16" @default.
• W1756388641 countsByYear W17563886412012 @default.
• W1756388641 countsByYear W17563886412014 @default.
• W1756388641 countsByYear W17563886412015 @default.
• W1756388641 countsByYear W17563886412016 @default.
• W1756388641 countsByYear W17563886412017 @default.
• W1756388641 countsByYear W17563886412018 @default.
• W1756388641 countsByYear W17563886412020 @default.
• W1756388641 countsByYear W17563886412021 @default.
• W1756388641 countsByYear W17563886412022 @default.
• W1756388641 crossrefType "journal-article" @default.
• W1756388641 hasAuthorship W1756388641A5025598471 @default.
• W1756388641 hasAuthorship W1756388641A5026161908 @default.
• W1756388641 hasAuthorship W1756388641A5031006818 @default.
• W1756388641 hasAuthorship W1756388641A5042045753 @default.
• W1756388641 hasAuthorship W1756388641A5049608650 @default.
• W1756388641 hasAuthorship W1756388641A5056712587 @default.
• W1756388641 hasAuthorship W1756388641A5073991373 @default.
• W1756388641 hasBestOaLocation W17563886411 @default.
• W1756388641 hasConcept C104317684 @default.
• W1756388641 hasConcept C150194340 @default.
• W1756388641 hasConcept C185592680 @default.
• W1756388641 hasConcept C190283241 @default.
• W1756388641 hasConcept C190727270 @default.
• W1756388641 hasConcept C202751555 @default.
• W1756388641 hasConcept C22801619 @default.
• W1756388641 hasConcept C2778260815 @default.

• next